scPharmaceuticals Inc. (SCPH) Dividend History

scPharmaceuticals Inc. is a pharmaceutical company focused on developing and commercializing innovative, FDA-approved products that address unmet medical needs. The company's primary focus is on hospital and specialty care markets, providing therapies that improve patient outcomes and healthcare efficiency.

25 Burlington Mall Road, Suite 203, Burlington, MA, 01803
Phone: 617-517-0730
Website: https://www.scpharmaceuticals.com

Dividend History

scPharmaceuticals Inc. currently does not pay dividends

Company News

MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases

MannKind Corporation announced it will acquire scPharmaceuticals for $303 million, expanding its presence in cardiometabolic and lung diseases. The deal includes an upfront cash payment of $5.35 per share and potential additional milestone payments, representing a 36% premium to scPharmaceuticals' recent trading price.

Benzinga

Featured Companies: MNKD
scPharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants

scPharmaceuticals Inc. announced a proposed underwritten public offering of shares of its common stock or pre-funded warrants to purchase shares. The offering is subject to market and other conditions.

GlobeNewswire Inc.
ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Lags Revenue Estimates

scPharmaceuticals (SCPH) delivered earnings and revenue surprises of 20% and 6.17%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research

Featured Companies: ALVO

Page data last updated 09/07/2025 06:33:12 UTC